Aortic Stenosis clinical trials

Explore recruiting aortic stenosis clinical trials.

Recruiting aortic stenosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Aortic Stenosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EMPagliflozin after Aortic Valve Replacement - the EMPAVR study - a randomized clinical trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Impact of an Angiotensin Receptor Blocker in Aortic Stenosis (ARBAS) – A Randomized Controlled Trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Impact of local tissue inflammation on intramyocardial conduction pathways post percutaneous valve : evaluation by positron emission tomography on exploratory cohort

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of antifibrotic therapy on regression of myocardial fibrosis after transcatheter aortic valve implantation (TAVI) in aortic stenosis patients with high fibrotic burden

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

Does Colchicine Reduce Progression of Aortic Valve Stenosis? Colchicine and Inflammation in Aortic Stenosis (CHIANTI): A placebo-controlled, double-blind, multicenter randomized trial.

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aortic Stenosis trials by city

Aortic Stenosis in Toronto Aortic Stenosis in Vancouver Aortic Stenosis in Montreal Aortic Stenosis in Calgary Aortic Stenosis in Edmonton Aortic Stenosis in Ottawa Aortic Stenosis in Winnipeg Aortic Stenosis in Quebec City Aortic Stenosis in Hamilton Aortic Stenosis in Kitchener Aortic Stenosis in London Aortic Stenosis in Halifax Aortic Stenosis in New York Aortic Stenosis in Los Angeles Aortic Stenosis in Chicago Aortic Stenosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease